Improving Radon Education and Awareness in Cancer Patients and Their Extended Community

July 15, 2026 updated by: University of Utah
Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. This is a pilot study to develop and evaluate the impact of a clinic-based intervention that educates cancer survivors and their caregivers/families about radon and radon testing. This study will enroll survivors, caregivers, and interested family members or friends in this intervention because they are important decision-makers with respect to the survivors' cancer care and well-being. This intervention would occur in clinics that treat lung cancer as well as clinics that treat cancers for which radon is being investigated as a contributor to their etiology (e.g. breast, skin melanoma, gastrointestinal).

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84112
        • Huntsman Cancer Institute/ University of Utah
        • Contact:
        • Principal Investigator:
          • Judy Ou, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult age 18 or older
  • Patient of HCI or friend/family or caregiver of patient of HCI (eligible if living in same home or different homes)
  • Resident of Utah, Wyoming, Idaho, Montana, or Nevada
  • Able to provide consent

Exclusion Criteria:

  • Below age 18
  • Resident of a state other than Utah, Wyoming, Idaho, Montana, or Nevada
  • Not able to provide consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Radon Educational Session
One short, educational intervention presentation will be given. The educational component is estimated to take 15-30 minutes, depending on how many questions people have.

A study staff member will deliver a short educational intervention about radon via PowerPoint with a standardized script to participants.

The intervention can be delivered online or in person. If in person, the caregiver and patient will listen to the presentation given by the study team member. If done online, the presentation will be conducted by a study team member using secured video conference software (e.g. Zoom, Teams).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Radon Knowledge
Time Frame: up to 1 day
To compare participants' pre- and post-intervention knowledge about radon based on demographics and estimated residential radon levels. Radon knowledge will be assessed using a questionnaire with total scores ranging from 0 to 5, where higher scores indicate greater radon knowledge and lower scores indicate less radon knowledge.
up to 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of Participants that Test for Radon
Time Frame: up to 4 weeks
To identify the proportion of participants that test for radon after the intervention according to demographics, estimated residential radon levels, and offered financial incentive.
up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Judy Ou, PhD, Huntsman Cancer Institute/ University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Study Registration Dates

First Submitted

July 7, 2026

First Submitted That Met QC Criteria

July 15, 2026

First Posted (Actual)

July 17, 2026

Study Record Updates

Last Update Posted (Actual)

July 17, 2026

Last Update Submitted That Met QC Criteria

July 15, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 192718

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivorship

Clinical Trials on Educational Presentation

Subscribe